Sulfasalazine-Induced Reduction of Glutathione Levels in Breast Cancer Cells: Enhancement of Growth-Inhibitory Activity of Doxorubicin

Vishal S. Narang,Giovanni M. Pauletti,Peter W. Gout,Donna J. Buckley,Arthur R. Buckley

Sulfasalazine-Induced Reduction of Glutathione Levels in Breast Cancer Cells: Enhancement of Growth-Inhibitory Activity of Doxorubicin

2007

Vishal S. Narang
Giovanni M. Pauletti
Peter W. Gout
Donna J. Buckley
Arthur R. Buckley

Background: We previously showed that the anti-inflammatory drug, sulfasalazine (salicylazosulfapyridine, SASP), can arrest proliferation of MCF-7 and MDA-MB-231 mammary cancer cell

Keywords:

Immunology
Sulfasalazine
Breast cancer
Glutathione
Biology
Cancer cell
Doxorubicin
Glutamate receptor
Methotrexate
Inhibitory postsynaptic potential
breast cancer cells
Drug
growth inhibitory
Pharmacology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations